Ingeborg Tinhofer-Keilholz

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Anja E. Hauser

GERMANY

View details

Steffi Pigorsch

Technical University of Munich

GERMANY

View details

Maja Guberina

University Hospital Essen

GERMANY

View details

Alberto D'Angelo

University of Bath

UNITED KINGDOM

View details

Konrad Klinghammer

charité university hospital

GERMANY

View details

Huseyin Kilili

University of Bath

UNITED KINGDOM

View details

Panagiotis Balermpas

University Hospital of Zurich

SWITZERLAND

View details

Paul Ziegler

University Hospital Frankfurt

GERMANY

View details

Stefan Bagby

University of Bath

UNITED KINGDOM

View details

Paul Jank

Head of Translational Research Laboratory

GERMANY

View details

Steffen Löck

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ingeborg Tinhofer-Keilholz

Research Interests

Explore related searches

Contact this professor

Articles (10)

Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses

Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?

Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC.

Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients.

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT.

Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers.

Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.

Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.

Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.

Collaborators (11)

Anja E. Hauser

Steffi Pigorsch

Maja Guberina

Alberto D'Angelo

Konrad Klinghammer

Huseyin Kilili

Panagiotis Balermpas

Paul Ziegler

Stefan Bagby

Paul Jank

Steffen Löck

Make your next move.